 Intraocular tissue plasminogen activator rabbit model traumatic hyphema Tissue plasminogen activator clearance traumatic hyphema rabbit model neodymium-YAG laser iris vessels traumatic hyphema Tissue plasminogen activator mL anterior chamber hours creation hyphema control groups receiving salt solution receiving treatment comparison multivariate analysis covariance difference hyphema clearance groups days days tissue plasminogen activator treatment mean size clot anterior chamber original hyphema control eyes original clot day Treatment animals tissue plasminogen activator doses IU IU substantial increase repeated bleeding episodes rabbit model use tissue plasminogen activator rabbit model traumatic hyphema clearance blood anterior chamber clot size clinical benefit questionable